Recently, SLC16A1 has been shown to be upregulated in HNSCC tumour tissues compared to adjacent normal marginal tissues, emphasising its potential oncogenic role in cancer progression likely through the NF-κB pathway [45]. This evidence concerns the gene SLC16A1 and neoplasm.